Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 714 (USA) (Dr. Clarke)
· consented 2013-08-15
Adverse events
1
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Moderate ATRIOVENTRICULAR BLOCK SECOND DEGREE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-08-13 (study day -2.0); relationship: NONE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.